Literature DB >> 10471076

The paraxanthine:caffeine ratio in serum or in saliva as a measure of CYP1A2 activity: when should the sample be obtained?

O Spigset1, S Hägg, E Söderström, R Dahlqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10471076

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN： 0960-314X


× No keyword cloud information.
  12 in total

1.  Effect of caffeine on clozapine pharmacokinetics in healthy volunteers.

Authors:  S Hägg; O Spigset; T Mjörndal; R Dahlqvist
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

Review 2.  Alternative Sampling Strategies for Cytochrome P450 Phenotyping.

Authors:  Pieter M M De Kesel; Willy E Lambert; Christophe P Stove
Journal:  Clin Pharmacokinet       Date:  2016-02       Impact factor: 6.447

3.  Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.

Authors:  Janne T Backman; Marika T Granfors; Pertti J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2006-04-27       Impact factor: 2.953

4.  Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.

Authors:  Janne T Backman; Marjo J Karjalainen; Mikko Neuvonen; Jouko Laitila; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

5.  Variability of cytochrome P450 1A2 activity over time in young and elderly healthy volunteers.

Authors:  T Simon; L Becquemont; B Hamon; E Nouyrigat; Y Chodjania; J M Poirier; C Funck-Brentano; P Jaillon
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

6.  Parkinson's disease and CYP1A2 activity.

Authors:  J T Forsyth; R A Grünewald; A Rostami-Hodjegan; M S Lennard; H J Sagar; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

7.  Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity.

Authors:  Dimiter Terziivanov; Kristina Bozhinova; Velislava Dimitrova; Ivanka Atanasova
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretation.

Authors:  Marjo J Karjalainen; Pertti J Neuvonen; Janne T Backman
Journal:  Eur J Clin Pharmacol       Date:  2007-07-06       Impact factor: 2.953

9.  Salivary caffeine metabolic ratio in alcohol-dependent subjects.

Authors:  Veerapol Kukongviriyapan; Laddawan Senggunprai; Auemduan Prawan; Danu Gaysornsiri; Upa Kukongviriyapan; Jareerat Aiemsa-Ard
Journal:  Eur J Clin Pharmacol       Date:  2004-03-12       Impact factor: 2.953

Review 10.  Applications of CYP450 testing in the clinical setting.

Authors:  C F Samer; K Ing Lorenzini; V Rollason; Y Daali; J A Desmeules
Journal:  Mol Diagn Ther       Date:  2013-06       Impact factor: 4.074
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.